Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
NCT ID: NCT01479725
Last Updated: 2017-03-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
8 participants
INTERVENTIONAL
2011-03-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
NCT03143920
Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial
NCT01659723
HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia)
NCT03693001
Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis
NCT01069263
Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
NCT00704457
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ulcerative IC
HBOT for ulcerative IC
HBOT
HBOT
Non-Ulcerative IC
HBOT for non-ulcerative IC
HBOT
HBOT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HBOT
HBOT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Urinary frequency of at least 8 times per 24 hours period.
* Patients with ulcerative IC must have undergone previous biopsy negative for cancer.
* Patients must agree to not begin any additional treatment for IC until study completion.
Exclusion Criteria
* Patients dependent on intermittent catheterization or indwelling catheter to empty bladder.
* Any imminent change in residence, which could compromise compliance.
* Unlikely to be compliant due to unmanaged medical or psychological problems.
* Severe debilitating concurrent medical conditions.
* A history of pelvic radiation, bladder stone, bladder cancer or cancer in situ, or urethral cancer.
* Precious bladder or neurologic surgery which has affected bladder function.
* Currently has an active urethral stone, ureteral stone or urethral diverticulum.
* Subject misses more than 10 treatments.
* Severe claustrophobia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
William Beaumont Hospitals
OTHER
Kenneth Peters, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenneth Peters, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Peters, MD
Role: PRINCIPAL_INVESTIGATOR
Beaumont Hospital, Royal Oak
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beaumont Hospital
Royal Oak, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-247
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.